Hepatitis C virus genotypes and subtypes circulating in Mainland China

Emerging Microbes and Infections

Volumn 6, Issue 11, 2017, Pages

  Chen, Ying ^a,b   Yu, Changshun ^a,b   Yin, Xueru ^c   Guo, Xiaolei ^a   Wu, Shangwei ^a,b   Hou, Jinlin ^c  

^a Guangzhou Kingmed Center for Clinical Laboratory   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

genotyping; hepatitis C virus; subtyping

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CHINA; FEMALE; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 1; HEPATITIS C VIRUS GENOTYPE 2; HEPATITIS C VIRUS GENOTYPE 3; HEPATITIS C VIRUS GENOTYPE 6; HEPATITIS C VIRUS SUBTYPE 1A; HEPATITIS C VIRUS SUBTYPE 1B; HEPATITIS C VIRUS SUBTYPE 2A; HEPATITIS C VIRUS SUBTYPE 2B; HEPATITIS C VIRUS SUBTYPE 3A; HEPATITIS C VIRUS SUBTYPE 3B; HEPATITIS C VIRUS SUBTYPE 6A; HEPATITIS C VIRUS SUBTYPE 6B; HEPATITIS C VIRUS SUBTYPE 6E; HEPATITIS C VIRUS SUBTYPE 6G; HEPATITIS C VIRUS SUBTYPE 6J; HEPATITIS C VIRUS SUBTYPE 6N; HEPATITIS C VIRUS SUBTYPE 6Q; HEPATITIS C VIRUS SUBTYPE 6R; HEPATITIS C VIRUS SUBTYPE 6U; HEPATITIS C VIRUS SUBTYPE 6V; HEPATITIS C VIRUS SUBTYPE 6W; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; VIRUS DETECTION; VIRUS LOAD; CLASSIFICATION; GENETIC VARIATION; GENETICS; GENOTYPE; HEPACIVIRUS; ISOLATION AND PURIFICATION; MOLECULAR EPIDEMIOLOGY; VIROLOGY;

CHINA; COINFECTION; FEMALE; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY;

EID: 85032629459     PISSN: None     EISSN: 22221751     Source Type: Journal    
DOI: 10.1038/emi.2017.77     Document Type: Article

References (33)

1. MohdHanafiah K, Groeger J, Flaxman AD et al Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342
2. Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol 2013; 28(Suppl 1): 7-10
3. Messina JP, Humphreys I, Flaxman A et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015; 61: 77-87
4. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 2007; 18: 352-358
5. Cuypers L, Ceccherini-Silberstein F, Van Laethem K et al. Impact of HCV genotype on treatment regimens and drug resistance: a snapshot in time. Rev Med Virol 2016; 26: 408-434
6. Chinese Society of Hepatology CSoID. [Guidelines for prevention and therapy for hepatitis C]. Chin J Exp Clin Infect Dis 2015; 9: 590-607
7. Fu Y, Wang Y, Xia W et al. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 2011; 18: 42-52
8. Murphy DG, Sablon E, Chamberland J et al. Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol 2015; 53: 967-972
9. Yan Z, Fan K, Wang Y et al. Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china. Hepat Mon 2012; 12: 196-204
10. Bao YP, Liu ZM, Lian Z et al. Prevalence and correlates of HIV and HCV infection among amphetamine-type stimulant users in 6 provinces in China. J Acquir Immune Defic Syndr 2012; 60: 438-446
11. Rao H, Wei L, Lopez-Talavera JC et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2014; 29: 545-553
12. Ray SC, Mao Q, Lanford RE et al. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000; 74: 3058-3066
13. Ray SC, Arthur RR, Carella A et al. Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis 2000; 182: 698-707
14. Li Q, Yao Y, Shen Y et al. Assessment of HCV genotypes in Yunnan Province of Southwest China. Virus genes 2017; 53: 190-196
15. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014; 61 (1 Suppl): S58-S68
16. Gower E, Estes C, Blach S et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61(1 Suppl): S45-S57
17. Mao XR, Zhang LT, Jiang N et al. [Distribution of HCV genotypes in Chinese Han population with chronic hepatitis C]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2015; 44: 417-422
18. Doi H, Apichartpiyakul C, Ohba KI et al. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 1996; 34: 569-574
19. Ruta S, Cernescu C. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World J Gastroenterol 2015; 21: 10811-10823
20. Ju W, Yang S, Feng S et al. Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J 2015; 12: 109
21. Li C, Barnes E, Newton PN et al. An expanded taxonomy of hepatitis C virus genotype 6: Characterization of 22 new full-length viral genomes. Virology 2015; 476: 355-363
22. Dashan Hu WZ, Xue R, Li H. [Analysis on genotype and route of infection for 215 Hepatitis C cases in Nanjing and Guangdong areas]. Jiangsu Med J 2014; 40: 597-598
23. Gammal RS, Spooner LM, Abraham GM. Failed triple therapy in a treatmentexperienced patient with genotype 6 hepatitis C infection. Am J Health Syst Pharm 2014; 71: 204-208
24. Cai Q, Zhao Z, Liu Y et al. Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int J Mol Med 2013; 31: 347-352
25. Tao Wu HL, Xiong L, Wang J et al. [Application of PCR fluorescent probe in identifying genotypes of HCV]. Chin J Clin Infect Dis 2017; 10: 37-42
26. European Association for Study of L. EASL Recommendations on Treatment of Hepatitis C 2015. J Hepatol 2015; 63: 199-236
27. Wedemeyer H, Duberg AS, Buti M et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21(Suppl 1): 60-89
28. Zeuzem S, Jacobson IM, Baykal T et al. Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370: 1604-1614
29. Feld JJ, Kowdley KV, Coakley E et al. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370: 1594-1603
30. Hezode C, Asselah T, Reddy KR et al. Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial. Lancet 2015; 385: 2502-2509
31. Hsu CS. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl JMed 2013; 369: 678
32. Zeuzem S, Dusheiko GM, Salupere R et al. Sofosbuvir and ribavirin in HCV genotypes 2 and 3. N Engl J Med 2014; 370: 1993-2001
33. Gane EJ, Hyland RH, An D et al. Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gastroenterology 2015; 149: 1454-1461. e1451